Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Center For Neuromusculoskeletal Restorative Medicine Limited manages 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners and 2 distinct art units. MOSHER, ERIC PARKER is the busiest examiner, holding 1 pending action. This means each of the 2 pending office actions is assigned to a different examiner.
The presence of 2 distinct examiners and 2 distinct art units indicates that the company's 2 pending office actions are being reviewed in isolation from one another. MOSHER, ERIC PARKER is one of the two examiners currently evaluating the company's biotechnology applications. Because the actions are in 2 distinct art units, they likely involve different technical sub-specialties within the pharmaceutical field. Practitioners should prepare for two separate prosecution tracks, as the data shows no overlap in the examiners or the art units for these 2 pending office actions. Each of the 2 pending office actions requires a unique strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
| SHIAO, REI TSANG | 1 | 79.9% | -33.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18844067 | COMPOUNDS FOR THE MEASUREMENT OF THE OXYGEN CONCENTRATION | MOSHER, ERIC PARKER | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18844067 | COMPOUNDS FOR THE MEASUREMENT OF THE OXYGEN CONCENTRATION | MOSHER, ERIC PARKER | 1612 | §101§103§112 | Non-Final OA | — | Pending | Sep 05, 2024 |
| 18592683 | USE OF MARAVIROC IN PREPARATION OF DRUGS FOR TREATMENT OF MUSCLE DEGENERATIVE DISEASES | SHIAO, REI TSANG | 1691 | §103 | Final Rejection | — | Pending | Mar 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCenter For Neuromusculoskeletal Restorative Medicine Limited has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Eric Parker Mosher has the most, with 1 of Center For Neuromusculoskeletal Restorative Medicine Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
